_version_ 1784711195687649280
author Nishikimi, Akihiko
Watanabe, Ken
Watanabe, Atsushi
Yasuoka, Mikako
Watanabe, Ryota
Fujiwara, Mitsuhiro
Oshima, Hironori
Nakagawa, Takeshi
Kitagawa, Yuichi
Tokuda, Haruhiko
Washimi, Yukihiko
Niida, Shumpei
Kojima, Masayo
author_facet Nishikimi, Akihiko
Watanabe, Ken
Watanabe, Atsushi
Yasuoka, Mikako
Watanabe, Ryota
Fujiwara, Mitsuhiro
Oshima, Hironori
Nakagawa, Takeshi
Kitagawa, Yuichi
Tokuda, Haruhiko
Washimi, Yukihiko
Niida, Shumpei
Kojima, Masayo
author_sort Nishikimi, Akihiko
collection PubMed
description
format Online
Article
Text
id pubmed-9121650
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher The British Infection Association. Published by Elsevier Ltd.
record_format MEDLINE/PubMed
spelling pubmed-91216502022-05-20 Immune responses to COVID-19 vaccine BNT162b2 in workers at a research institute in Japan: 6-month follow-up survey Nishikimi, Akihiko Watanabe, Ken Watanabe, Atsushi Yasuoka, Mikako Watanabe, Ryota Fujiwara, Mitsuhiro Oshima, Hironori Nakagawa, Takeshi Kitagawa, Yuichi Tokuda, Haruhiko Washimi, Yukihiko Niida, Shumpei Kojima, Masayo J Infect Letter to the Editor The British Infection Association. Published by Elsevier Ltd. 2022-08 2022-05-20 /pmc/articles/PMC9121650/ /pubmed/35605803 http://dx.doi.org/10.1016/j.jinf.2022.05.016 Text en © 2022 The British Infection Association. Published by Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Letter to the Editor
Nishikimi, Akihiko
Watanabe, Ken
Watanabe, Atsushi
Yasuoka, Mikako
Watanabe, Ryota
Fujiwara, Mitsuhiro
Oshima, Hironori
Nakagawa, Takeshi
Kitagawa, Yuichi
Tokuda, Haruhiko
Washimi, Yukihiko
Niida, Shumpei
Kojima, Masayo
Immune responses to COVID-19 vaccine BNT162b2 in workers at a research institute in Japan: 6-month follow-up survey
title Immune responses to COVID-19 vaccine BNT162b2 in workers at a research institute in Japan: 6-month follow-up survey
title_full Immune responses to COVID-19 vaccine BNT162b2 in workers at a research institute in Japan: 6-month follow-up survey
title_fullStr Immune responses to COVID-19 vaccine BNT162b2 in workers at a research institute in Japan: 6-month follow-up survey
title_full_unstemmed Immune responses to COVID-19 vaccine BNT162b2 in workers at a research institute in Japan: 6-month follow-up survey
title_short Immune responses to COVID-19 vaccine BNT162b2 in workers at a research institute in Japan: 6-month follow-up survey
title_sort immune responses to covid-19 vaccine bnt162b2 in workers at a research institute in japan: 6-month follow-up survey
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9121650/
https://www.ncbi.nlm.nih.gov/pubmed/35605803
http://dx.doi.org/10.1016/j.jinf.2022.05.016
work_keys_str_mv AT nishikimiakihiko immuneresponsestocovid19vaccinebnt162b2inworkersataresearchinstituteinjapan6monthfollowupsurvey
AT watanabeken immuneresponsestocovid19vaccinebnt162b2inworkersataresearchinstituteinjapan6monthfollowupsurvey
AT watanabeatsushi immuneresponsestocovid19vaccinebnt162b2inworkersataresearchinstituteinjapan6monthfollowupsurvey
AT yasuokamikako immuneresponsestocovid19vaccinebnt162b2inworkersataresearchinstituteinjapan6monthfollowupsurvey
AT watanaberyota immuneresponsestocovid19vaccinebnt162b2inworkersataresearchinstituteinjapan6monthfollowupsurvey
AT fujiwaramitsuhiro immuneresponsestocovid19vaccinebnt162b2inworkersataresearchinstituteinjapan6monthfollowupsurvey
AT oshimahironori immuneresponsestocovid19vaccinebnt162b2inworkersataresearchinstituteinjapan6monthfollowupsurvey
AT nakagawatakeshi immuneresponsestocovid19vaccinebnt162b2inworkersataresearchinstituteinjapan6monthfollowupsurvey
AT kitagawayuichi immuneresponsestocovid19vaccinebnt162b2inworkersataresearchinstituteinjapan6monthfollowupsurvey
AT tokudaharuhiko immuneresponsestocovid19vaccinebnt162b2inworkersataresearchinstituteinjapan6monthfollowupsurvey
AT washimiyukihiko immuneresponsestocovid19vaccinebnt162b2inworkersataresearchinstituteinjapan6monthfollowupsurvey
AT niidashumpei immuneresponsestocovid19vaccinebnt162b2inworkersataresearchinstituteinjapan6monthfollowupsurvey
AT kojimamasayo immuneresponsestocovid19vaccinebnt162b2inworkersataresearchinstituteinjapan6monthfollowupsurvey